Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Ascites01:19

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dome-shaped macula in high myopia: Prevalence and clinical characteristics in a French cohort.

Acta ophthalmologica·2026
Same author

Genome-wide discovery reveals 30 loci for choroidal thickness and uncovers potential causal links with angle-closure glaucoma.

medRxiv : the preprint server for health sciences·2026
Same author

Re: Shaheen et al: Efficacy and safety of anti-VEGF Injections and surgery for age-related macular degeneration-related submacular hemorrhage: a systematic review and meta-analysis (Ophthalmol Retina. 2025;9:4-12).

Ophthalmology. Retina·2026
Same author

I-SCREEN: Development of an AI-based infrastructure for community-wide screening and prediction of progression in age-related macular degeneration providing accessible shared care.

Eye (London, England)·2026
Same author

The AROMA Dataset for Automatic Detection of Artifact Type and Severity in Retinal Optical Coherence Tomography Angiography.

Ophthalmic research·2026
Same author

Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry.

Ophthalmology. Retina·2026
Same journal

Long-term smoking and early-onset diabetic retinopathy in young-onset type 2 diabetes.

European journal of ophthalmology·2026
Same journal

Optimizing mitomycin C in photorefractive keratectomy: A paired-eye comparison of 15- versus 30-second applications.

European journal of ophthalmology·2026
Same journal

Honeycomb Keratopathy due to Rho-kinase inhibitor therapy.

European journal of ophthalmology·2026
Same journal

Mendelian randomisation in ophthalmology: An overview and practical guide for clinicians.

European journal of ophthalmology·2026
Same journal

Association of interleukin-6 pathway inhibition with risk of age-related macular degeneration: A propensity-matched cohort study.

European journal of ophthalmology·2026
Same journal

Clinical characteristics of thyroid eye disease with restrictive strabismus.

European journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: May 15, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Macular edema: miscellaneous.

Catherine Creuzot-Garcher1, Jost Jonas, Sebastian Wolf

  • 1Department of Ophthalmology, University Hospital, Dijon, France. catherine.creuzot-garcher@chu-dijon.fr

European Journal of Ophthalmology
|December 25, 2012
PubMed
Summary
This summary is machine-generated.

This article discusses macular edema causes and prognoses. While some causes like ocular melanoma radiotherapy have poor outcomes, others from retinal detachment or treatments are temporary, with surgical recovery varying by condition.

Related Experiment Videos

Last Updated: May 15, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Area of Science:

  • Ophthalmology
  • Retinal Diseases
  • Macular Edema Pathophysiology

Background:

  • Macular edema presents diverse etiologies and prognoses.
  • Understanding these causes is crucial for effective patient management.
  • Previous research highlights varying outcomes based on underlying conditions.

Purpose of the Study:

  • To provide practical information on managing various causes of macular edema.
  • To differentiate prognoses associated with different macular edema etiologies.
  • To guide treatment strategies based on the specific cause of macular edema.

Main Methods:

  • Review of existing literature on macular edema causes and treatments.
  • Analysis of functional prognosis based on underlying ocular or systemic conditions.
  • Categorization of macular edema based on etiology (e.g., post-radiotherapy, post-retinal detachment, epiretinal membranes, vitreomacular traction, hemangiomas, macroaneurysms).

Main Results:

  • Macular edema post-ocular melanoma radiotherapy often has a poor prognosis.
  • Edema following retinal detachment or certain treatments may be temporary.
  • Epiretinal membranes and vitreomacular traction are significant causes of poor visual recovery, with long delays for surgical improvement.
  • Symptomatic hemangiomas or macroaneurysms may be treated similarly to diabetic macular edema or exudative macular degeneration.

Conclusions:

  • Prognosis and management of macular edema are highly dependent on its underlying cause.
  • Timely and appropriate treatment, guided by etiology, is essential for optimizing visual outcomes.
  • Further research may refine treatment protocols for specific challenging cases of macular edema.